Advertisement
Advertisement

TRIB

TRIB logo

Trinity Biotech plc

13.20
USD
Sponsored
+0.77
+6.19%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

13.14

-0.06
-0.45%

Trinity Biotech plc Profile

About

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.

Info & Links

CEO

John Gillard

Headquarters

IDA BUSINESS PARK, BRAY
WICKLOW, L2 A98 H5C8, IRELAND

Industry

Medical Products

Sector

Medical

Website

https://www.trinitybiotech.com

Auditor

GRANT THORNTON

Share holders

--

Employees

287

Trinity Biotech plc Statistics

Valuation Measures

Market Capitalization2

8.87M

Enterprise Value

146.70M

Enterprise Value/EBITDA(ttm)

-15.92

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.18

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

39.61%

Operating Margin(ttm)

-70.06%

Profit Margin(ttm)

-72.34%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

29.57%

Return on Assets(ttm)

-32.13%

Income Statement

Revenue(ttm)

47.06M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

18.82M

EBITDA(ttm)3

-9.21M

Net Income Available to Common(ttm)

-32.97M

Diluted EPS(ttm)

-44.26

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-52.05%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

620.00K

% Held by Insiders

8.20%

% Held by Institutions

78.97%

Balance Sheet

Total Cash(mrq)

2.02M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

139.84M

Total Debt/Equity(mrq)

-184.67%

Current Ratio(mrq)

0.22%

Quick Ratio(mrq)

0.09%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.84

Free Cash Flow(ytd)

-1.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement